Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Operating activities:
Net loss	$ (8,251,037)	$ (10,029,359)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	12,393	13,698
Loss on sale or disposal of assets		6,761
Stock-based compensation expense	681,449	731,633
Common stock issued for advisory services		1,409,363
Warrant related expense, change in fair value, and other financing expenses	2,627,896
Non-cash interest expense	85,309	4,754
Changes in operating assets and liabilities:
Prepaid expenses, deposits and other assets	(68,189)	17,712
Accounts payable, accrued expenses and other liabilities	(1,249,735)	356,124
Net cash used in operating activities	(6,161,914)	(7,489,314)
Cash flows (used in) provided by investing activities:
Purchases of property and equipment	(64,002)	(2,331)
Purchase of certificate of deposit	(10,000,000)
Cash received in reverse merger transaction		8,500,602
Net cash (used in) provided by investing activities	(10,064,002)	8,498,271
Cash flows provided by financing activities:
Proceeds from the sale of Series A convertible preferred stock and warrants, net	22,129,774
Payment of offering costs for Series B convertible preferred stock	(43,311)
Net cash provided by financing activities	22,086,463
Net increase in cash and cash equivalents	5,860,547	1,008,957
Cash and cash equivalents at beginning of period	1,552,852	1,997,192
Cash and cash equivalents at end of period	7,413,399	3,006,149
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment in accounts payable and accrued expenses	(348,286)
Series B offering costs in accounts payable and accrued expenses	(50,103)
Series A cumulative preferred dividends	(546,305)
Conversion of accrued dividends related to convertible preferred stock	70,890
Conversion of convertible notes and related accrued interest into common stock		711,495
Consideration in connection with RestorGenex Corporation merger transaction		21,261,000
Series A Preferred Stock [Member]
Supplemental disclosure of non-cash investing and financing activities:
Series A cumulative preferred dividends	(546,305)
Convertible Preferred Stock [Member]
Supplemental disclosure of non-cash investing and financing activities:
Conversion of accrued dividends related to convertible preferred stock	$ 70,890